Geode Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $343K | Sell |
646,156
-372,330
| -37% | -$197K | ﹤0.01% | 3675 |
|
2025
Q1 | $450K | Buy |
1,018,486
+541,217
| +113% | +$239K | ﹤0.01% | 3581 |
|
2024
Q4 | $334K | Buy |
477,269
+21,789
| +5% | +$15.3K | ﹤0.01% | 3727 |
|
2024
Q3 | $661K | Sell |
455,480
-7,882
| -2% | -$11.4K | ﹤0.01% | 3499 |
|
2024
Q2 | $3.38M | Buy |
463,362
+14,053
| +3% | +$102K | ﹤0.01% | 2930 |
|
2024
Q1 | $2.66M | Buy |
449,309
+19,632
| +5% | +$116K | ﹤0.01% | 3005 |
|
2023
Q4 | $3.15M | Buy |
429,677
+12,887
| +3% | +$94.4K | ﹤0.01% | 2927 |
|
2023
Q3 | $1.62M | Buy |
416,790
+28,283
| +7% | +$110K | ﹤0.01% | 3145 |
|
2023
Q2 | $2.24M | Buy |
388,507
+207,624
| +115% | +$1.2M | ﹤0.01% | 3075 |
|
2023
Q1 | $1.18M | Buy |
180,883
+17,920
| +11% | +$116K | ﹤0.01% | 3270 |
|
2022
Q4 | $448K | Buy |
162,963
+12,728
| +8% | +$35K | ﹤0.01% | 3707 |
|
2022
Q3 | $438K | Buy |
150,235
+29,091
| +24% | +$84.8K | ﹤0.01% | 3787 |
|
2022
Q2 | $232K | Sell |
121,144
-96,254
| -44% | -$184K | ﹤0.01% | 4173 |
|
2022
Q1 | $1.76M | Sell |
217,398
-430
| -0.2% | -$3.49K | ﹤0.01% | 3313 |
|
2021
Q4 | $2M | Sell |
217,828
-20,241
| -9% | -$185K | ﹤0.01% | 3358 |
|
2021
Q3 | $2.98M | Buy |
238,069
+25,089
| +12% | +$314K | ﹤0.01% | 3185 |
|
2021
Q2 | $2.41M | Buy |
212,980
+13,822
| +7% | +$156K | ﹤0.01% | 3209 |
|
2021
Q1 | $3.02M | Buy |
199,158
+14,392
| +8% | +$218K | ﹤0.01% | 3049 |
|
2020
Q4 | $2.13M | Sell |
184,766
-1,557
| -0.8% | -$17.8K | ﹤0.01% | 3051 |
|
2020
Q3 | $1.44M | Sell |
186,323
-11,196
| -6% | -$86.7K | ﹤0.01% | 3056 |
|
2020
Q2 | $2.17M | Buy |
197,519
+17,454
| +10% | +$192K | ﹤0.01% | 2793 |
|
2020
Q1 | $1.97M | Buy |
180,065
+16,830
| +10% | +$184K | ﹤0.01% | 2682 |
|
2019
Q4 | $2.59M | Buy |
163,235
+19,510
| +14% | +$310K | ﹤0.01% | 2847 |
|
2019
Q3 | $2.12M | Buy |
143,725
+61,801
| +75% | +$912K | ﹤0.01% | 2910 |
|
2019
Q2 | $951K | Buy |
81,924
+20,341
| +33% | +$236K | ﹤0.01% | 3255 |
|
2019
Q1 | $665K | Buy |
61,583
+24,677
| +67% | +$266K | ﹤0.01% | 3317 |
|
2018
Q4 | $300K | Buy |
36,906
+8,885
| +32% | +$72.3K | ﹤0.01% | 3557 |
|
2018
Q3 | $455K | Buy |
+28,021
| New | +$455K | ﹤0.01% | 3496 |
|